cardiovascular diseases
Conditions
Interventions
High risk group vs. Low-to-intermediate risk group:None
Sponsors
Qilu Hospital of Shandong University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged 18 years and older, regardless of gender; 2. No known history of cardiovascular diseases (such as coronary heart disease, heart failure, stroke, peripheral arterial disease); 3. No hospitalization for severe illnesses in the past six months; 4. Capable of wearing a 72-hour Holter monitor and completing 12-month follow-up; 5. Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Previously diagnosed atrial fibrillation, atrial flutter or persistent arrhythmias; 2. With implanted pacemaker or implantable cardioverter-defibrillator (ICD); 3. Moderate to severe valvular heart disease or cardiomyopathy (LVEF < 50%); 4. Chronic renal insufficiency (eGFR < 30 mL/min/1.73 m²); 5. Uncontrolled thyroid dysfunction; 6. Lactating women; 7. Receiving antiarrhythmic drug therapy at enrollment; 8. Severe skin diseases or allergy to electrode patches that prevents wearing the ambulatory electrocardiography recorder; 9. Life expectancy less than 1 year; 10. Any other conditions deemed inappropriate for participation by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection rate of clinically significant abnormal ECG findings; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment commencement rate;Medical expenses for patients undergoing treatment;Holter parameters; | — |
Countries
China
Contacts
Public ContactRuixue Yang
Qilu Hospital of Shandong University
Outcome results
None listed